Business
Notice of EGM
Notice of EGM.
About this update from Faron Pharmaceuticals Oy
[{"type":"text","content":"\n\nNOTICE OF faron pharmaceuticals LTD's extraordinary GENERAL MEETING\nShareholders of Faron Pharmaceuticals Ltd (the \"Company\") are notified of the Extraordinary General Meeting to be held on September 22, 2023 at 9:00 a.m. EEST (Finnish time) at BioCity, meeting room \"Ministeri\" at Tykistökatu 6, FI-20520 Turku, Finland. The registration of attendees and the distribution of voting slips will commence at the meeting venue at 8:30 a.m. EEST (Finnish time).\nThe Board of Directors of the Company (the \"Board\") has resolved to convene the Extraordinary General Meeting to resolve on the election of new members of the Board and to resolve on the amendment of the Company's Option Plan 2015.\nA. MATTERS ON THE AGENDA OF THE EXTRAORDINARY GENERAL MEETING\n \n1. Opening of the meeting\n \n2. Calling the meeting to order\n \n3. Election of persons to scrutinise the minutes and to supervise the counting of votes\n \n4. Recording the legality of the meeting\n \n5. Recording the attendance at the meeting and adoption of the list of votes\n \n6. Resolution on the number of members of the Board \n \nThe Board proposes, based on the proposal of the nomination committee, that the number of the members of the Board would be resolved to be seven (7). \n \n7. Election of new members of the Board \n \nThe Board proposes, based on the proposal of the nomination committee, that Christine Roth and Marie-Louise Fjällskog be elected as new members to the Board for a term that ends at the close of the next Annual General Meeting.\n \nChristine Roth, citizen of the United States, currently serves as an Executive Vice President for Bayer Pharmaceuticals' Global Oncology Business Unit and a member of the board of directors of Vividion Therapeutics. She is independent of the Company and its significant shareholders.\n \nMarie-Louise Fjällskog, a citizen of Sweden and the United States, currently serves as Faron Pharmaceuticals Ltd's Chief Medical Officer. She is non-independent of the Company, but she is independent of its significant shareholders.\n \nChristine Roth and Marie-Louise Fjällskog have given their consent for the election. A description of both Board member candidate is availa...